Aurinia Pharmaceuticals Inc.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
2 sales (2 not pre-planned) · 5 purchases
- Robertson Stephen P.Chief Legal Officer · Sep 10, 2026Sold 11,939 sharesabout $190 thousand · not pre-planned
- Robertson Stephen P.Chief Legal Officer · Aug 21, 2026Sold 20,975 sharesabout $356 thousand · not pre-planned
- TANG KEVINChief Executive Officer · Jun 2, 2026Bought 206,005 sharesabout $3.1 million ·
- TANG KEVINChief Executive Officer · Jun 1, 2026Bought 343,521 sharesabout $5.2 million ·
- TANG KEVINChief Executive Officer · Jun 1, 2026Bought 99 sharesabout $2 thousand ·
- TANG KEVINChief Executive Officer · May 29, 2026Bought 2,299 sharesabout $35 thousand ·
- TANG KEVINChief Executive Officer · May 29, 2026Bought 262,682 sharesabout $4.0 million ·
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.